Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age

BACKGROUND: The International Maternal, Pediatric, and Adolescent Clinical Trials P1060 trial demonstrated superior outcomes for HIV-infected children less than 3 years old initiating antiretroviral therapy (ART) with lopinavir/ritonavir compared to nevirapine, but lopinavir/ritonavir is four-fold c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AIDS
Main Authors: Ciaranello, Andrea L., Doherty, Kathleen, Penazzato, Martina, Lindsey, Jane C., Harrison, Linda, Kelly, Kathleen, Walensky, Rochelle P., Essajee, Shaffiq, Losina, Elena, Muhe, Lulu, Wools-Kaloustian, Kara, Ayaya, Samuel, Weinstein, Milton C., Palumbo, Paul, Freedberg, Kenneth A.
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2015
Assuntos:
Epidemiology and Social
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4536981/
https://ncbi.nlm.nih.gov/pubmed/25870982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000000672
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares